Myriad Genetics, Inc (NASDAQ: MYGN): Reassessing Prospects

Myriad Genetics, Inc (MYGN) concluded trading on Wednesday at a closing price of $4.27, with 12.57 million shares of worth about $53.69 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -76.26% during that period and on May 07, 2025 the price saw a […]